• Recursion CEO Chris Gibson on Accelerating the Biopharmaceutical Industry With AI - Ep. 230

  • Aug 7 2024
  • Length: 38 mins
  • Podcast

Recursion CEO Chris Gibson on Accelerating the Biopharmaceutical Industry With AI - Ep. 230

  • Summary

  • Techbio is a field combining data, technology and biology to enhance scientific processes — and AI has the potential to supercharge the biopharmaceutical industry further. In this episode of NVIDIA’s AI Podcast, host Noah Kravitz speaks with Chris Gibson, cofounder and CEO of Recursion, about how the company uses AI and machine learning to accelerate drug discovery and development at scale. Tune in to hear Gibson discuss how AI is transforming the biopharmaceutical industry by increasing efficiency and lowering discovery costs.
    Show more Show less

What listeners say about Recursion CEO Chris Gibson on Accelerating the Biopharmaceutical Industry With AI - Ep. 230

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.